# Nanospectra Biosciences, Inc.

- Location (FDA's records): Houston, TX
- FDA decisions: 2 (2022–2025): 2 510(k) clearances
- Product codes: GEX (2)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Diomed, Inc.: 1 (https://510kreport.com/company/diomed)
- Biotex, Inc.: 1 (https://510kreport.com/company/biotex)

## Recent decisions
- K243701: AuroLase® System (Jul 2, 2025)
- K202953: Aurolase Therapy, Laser Delivery Device (LDD) (Oct 3, 2022)

Source page: https://510kreport.com/company/nanospectra-biosciences